CUSIP: 46436E593
Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / IBOND DEC 2030
-
Total 13F shares
-
18,334,845
-
Share change
-
+2,305,119
-
Total reported value
-
$363,699,711
-
Price per share
-
$19.84
-
Number of holders
-
131
-
Value change
-
+$45,768,858
-
Number of buys
-
87
-
Number of sells
-
31
Security key
46436E593
Report period
Q2 2025
Institutions
131
Top holders
10
Reporting periods
Holder history for CUSIP 46436E593
Recent filing periods:
Top shareholders of IBTK - ISHARES TR - IBOND DEC 2030 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ISHARES TR - IBOND DEC 2030 (IBTK) as of Q2 2025
As of 30 Jun 2025,
ISHARES TR - IBOND DEC 2030 (IBTK) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,334,845 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, ENVESTNET ASSET MANAGEMENT INC, TITLEIST ASSET MANAGEMENT, LLC, D.A. DAVIDSON & CO., MERCER GLOBAL ADVISORS INC /ADV, Royal Bank of Canada, Waycross Investment Management Co, Legacy Private Trust Co., and Probity Advisors, Inc..
This page lists
131
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor |
Q1 2025 Shares |
Q2 2025 Shares |
Share Diff |
Share Chg % |
Q1 2025 Value $ |
Q2 2025 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.